| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.34 | 7e-12 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.23 | 9e-10 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-09 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-08 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-08 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.28 | 2e-07 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-07 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.2 | 5e-07 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.18 | 9e-07 |